High Dose Donor Hematopoietic Stem Cell Infusion for Relapsed/Refractory AML
Clinical trial NCT03080922 · UNKNOWN
Trial details
- NCT number
- NCT03080922
- Sponsor
- The Affiliated Hospital of the Chinese Academy of Military Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2018-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.